Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples